Wall St Price Targets

CSTL Price Forecast
Based on 12 analysts

+46% Upside
from $33.79 today

Castle Biosciences Inc (CSTL)’s 12-month stock price forecast through November 2027 has a consensus target of $49.47, implying 46% upside. The forecast is based on price targets from 12 Wall Street analysts.

CSTL Analyst Rating
Based on 9 analysts

avg. 5 of 5
Strong buy
9 100%
Buy
0 0%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate CSTL Strong buy, with 9 of 9 recommending Buy or Strong buy.

Castle Biosciences Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CSTL's stock price target?
Price Target
49.47 USD

According to Wall Street analysts, the average 1-year price target for CSTL is 49.47 USD with a low forecast of 40.4 USD and a high forecast of 63 USD.

What is the Revenue forecast for Castle Biosciences Inc?
Projected CAGR
7%

Over the last 7 years, the compound annual growth rate for Revenue has been 47%. The projected CAGR for the next 8 years is 7%.

What is the Gross Profit forecast for Castle Biosciences Inc?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 48%. The projected CAGR for the next 6 years is 8%.

Back to Top